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Abstract 
Introduction: Burkitt lymphoma (BL) is rare, but an aggressive malignancy. 
Central nervous system Burkitt lymphoma (CNSBL) is very rare. CNS 
Burkitt’s lymphoma is treated with high-dose chemotherapy and radiation. 
Radiotherapy in children younger than three years old may cause major CNS 
damage. 
Case report: A three-year-old boy presented with painful proptosis of the left 
eye. He underwent adenoidectomy 2 months before admitted to our center. 
Sleep difficulty was not resolved after surgery. Microscopic study of paranasal 
sinus biopsy and IHC confirmed the diagnosis of Burkitt Lymphoma. 
Conclusions: Inany patients presenting with painful proptosis, BL should be 
considered. Adenoid hyperplasia should not be considered as a sole cause of 
sleep difficulty. 
Keywords: Burkitt Lymphoma, Adenoid Hyperplasia, CNS Tumor, Non-
Hodgkin Lymphomas 
 
 
 
 
 
 
 
 
 
Introduction 
Non-hodgkin lymphomas is an uncommon cancer in children younger than 
5 year 
[1]
. Burkitt lymphoma (BL) (a form of B-cell non-Hodgkin lymphoma) 
is rare, but an aggressive malignancy with a tendency to disseminate to the 
bone marrow and meninges 
[2]
. Central nervous system involvement with non-
Hodgkin lymphoma (NHL) occurs in about 12% of children with BL 
[3]
. 
Primary central nervous system, Burkitt lymphoma, is very rare 
[4-7]. Burkitt’s 
lymphoma was first discovered in equatorial Africa 
[1]
. The most common 
places in the body for the disease to start in African children are the jaw, 
abdomen, but non African type Burkitt’s lymphoma tends to start in the 
abdomen and bone marrow.BL can affect tonsils and adenoids, too 
[8-9]
. The 
tumor is very aggressive and cangrowrapidly and make large masses. The mass 
can press on other organs, causing a number of very serious fatal 
complications, including airway obstruction, arrhythmias 
[10]
, obstruction or 
perforation of the bowel, renal tract obstruction, superior vena cava 
obstruction. CNS BL can cause increased intracranial pressure, headaches, 
vision problems, nausea and/or vomiting. BL may be diagnosed by blood test, 
bone marrow aspiration and/or biopsy, lymph node biopsy, abdominal fluid 
analysis, pleural fluid analysis and rarely paranasal sinus biopsy. Chest x-ray, 
bone scan and other imaging study are necessary to determine the extent of 
disease to select the best treatment. CNS Burkitt’s lymphoma is treated with 
high-dose chemotherapy and radiation 
[11]
. 
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Case presentation 
A three-year-old boy presented with left neck 
region mass and painful proptosis of the left eye. He 
complained intermittent blunt headache for 1 month. 
He underwent surgery for adenoid hyperplasia about 2 
months ago, because the patient had respiratory 
problem at the time of sleeping on that time. Brain 
MRI showed massive lesion in retro bulbar region 
extended to Para nasal sinus and temporal lobe. MRI 
indicated bone destruction in sella turcica region too 
(Fig 1). 
Paranasal sinus biopsy was done for him. 
Microscopic study showed small round cell tumors, 
more suggestion was Rhabdomyosarcoma. The clinical 
aspect was compatible with Rhabdomyosarcoma 
(RMS), but immune histochemistery suggested the 
expression of CD 10 and a Ki-67 proliferation fraction 
of virtually more than 90% which were compatible 
with BL.  
Bone marrow aspiration and biopsy were 
normal.CSF analysis was normal, too. Plain Chest X 
Ray, Chest CT scan and abdominal CT scan were 
normal. Intensive chemotherapy (BFM-90) and 
intrathecal (IT) chemotherapy were initiated. Chemo-
therapy reduced the neck region mass rapidly but 
deficits partially improved in the visual acuity and 
proptosis. Unfortunately, after 1 year intensive 
chemotherapy, CSF showed many blast cells.  
Plain Chest X Ray, Chest CT scan and abdominal 
CT scan were normal again. Bone marrow aspiration, 
bone marrow biopsy and flow cytometry were normal 
again. The patient was treated with intrathecal three 
times a week and despite of his low age, radiotherapy 
was considered. Surprisingly control MRI became 
normal in compare with first assessment (Figure 2). 
CSF became normal again after treatment. The patient 
is in complete remission now. 
 
 
Discussion 
A few cases of Central Nervous System Burkitt 
Lymphoma (CNSBL) in children have been reported in 
English literature 
[12-16]
. Many cases who reported in 
the literature were not younger than 5 years old, 
whereas our case was very young (3 years old). Our 
study like as other researches showed that in any 
patient presenting with painful proptosis and vision 
loss or blunt headache, a diagnosis of BL should be 
considered 
[17 , 18]
. Burkitt's lymphoma is an important 
cause of childhood blindness in Nigeria and the orbital 
disease is mainly extra ocular 
[19]
.  
In our patient, cranial nerve palsy including six and 
seven nerve palsy occurred as a cause of vision 
problem. Our study showed indicated that adenoid 
hyperplasia should not be considered as a sole cause of 
sleep difficulty and respiratory problem. Because of 
diagnostic and therapeutic difficulties of Non-Hodgkin 
lymphomas of the nasopharynx in children, the 
physician should be aware of nasopharyngeal 
problems. Lymphomas of nasopharynx and CNS BL in 
a child such as our patient cause diagnostic problems 
because of their early stage pseudo inflammatory 
manifestation. Special attention should be paid to 
perform imaging studies (MRI/CT), which are useful in 
reaching the proper diagnosis 
[20]
. In one study, BL 
misdiagnosed as advanced retinoblastoma because of 
globe invasion and destruction 
[21]
.  
The presentation of rhabdomyosarcoma was 
supposed to be in that study as our study. The correct 
diagnosis was obtained from the histology of the 
extenterated eye in both studies. Preoperative 
therapeutic trial was chemotherapeutic agents in such 
cases suggested to avoid unnecessary exenteration.  
Although the treatment regimens are different 
including surgery, radiotherapy, and systemic and 
intrathecal chemotherapy, intensive short-course 
chemotherapy combining with intrathecal injection 
regimen are recommend to treat systemic BL 
[22]
, 
whereas for Central Nervous System Lymphoma 
(CNSL), the high-dose MTX-based chemotherapy 
regimen has been commonly used. Chemotherapy after 
using cranial radiotherapy improves median disease-
free and overall survival of up to 30 to 40 months from 
the survival of 12 to 18 months 
[23]
.  
Our case is in remission after radiotherapy. 
Moreover, a pediatric series of CNSL has reported that 
immunocompetent and immunodeficient children with 
CNSL may be cured with chemotherapy alone without 
CRT. However, treatment of young age patient is very 
difficult for drug toxicity and impossibility of 
radiotherapy. Our patient experienced many time 
hospitalization even mechanical ventilation due to drug 
toxicity and infections 
[24]
.  
Today's, despite of progression of chemotherapy in 
Non-Hodgkin Lymphomas, CNS involvement or poor 
response to chemotherapy was worse prognostic 
factors; therefore, future studies addressing this 
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therapeutic challenge are warranted. Because of rapid 
progression of BL and considering that it responds well 
to treatment, if the disease is diagnosed at early stages, 
a diagnostic work-up including a tissue biopsy should 
be initiated immediately after BL is suspected.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1: Brain MRI of patient with CNS BL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2: Brain MRI of patient with CNS BL after treatment
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